The number of identified lymph node metastases increases continuously with increased total lymph node recovery in pT3 colon cancer

被引:19
作者
Tornroos, Alexander [1 ]
Garvin, Stina [1 ]
Olsson, Hans [1 ]
机构
[1] Linkoping Univ Hosp, Div Pathol, Dept Pathol & Genet, SE-58185 Linkoping, Sweden
关键词
COLORECTAL-CANCER; MINIMUM NUMBER; PROGNOSTIC-SIGNIFICANCE; ADJUVANT THERAPY; GEWF SOLUTION; CARCINOMA; SPECIMENS; RESECTIONS; SURVIVAL; HARVEST;
D O I
10.3109/02841860902896097
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The positive correlation between the number of recovered benign lymph nodes and patient prognosis is well established for stage II colon cancer patients. One theory explaining this correlation focuses on potential understaging of cancer specimen, implying that a specimen with few examined lymph nodes is likely to be assigned a lower N-stage than the correct one. Understaging may be the result of an insufficient examination of the specimen post-operatively, whereby few lymph nodes are recovered and potential lymph node metastases are overlooked. This study aims to investigate the association between the total lymph node harvest and the number of lymph node metastases in colon cancer specimen. Material and methods. We studied the original pathology reports of 649 patients diagnosed with T3 adenocarcinoma of the colon at the Department of Clinical Pathology and Genetics at Linkoping University Hospital, Linkoping, Sweden between the years 2000 and 2008. Patient demographics, specimen staging data, and lymph node recovery data were collected for each case. Results. We found a positive association between the total lymph node harvest and the number of lymph node metastases per specimen. For every additional recovered lymph node 0.17 (95% CI: 0.15-0.19) metastases were detected (p<0.001). Discussion. Our results support the conclusion that there is no minimum number of recovered lymph nodes at which an accurate determination of nodal status can be assured. Rather than focusing on a recommended minimum number of nodes, efforts should be shifted towards developing methods assuring that colon cancer specimen are dissected in a standardized way that optimizes the lymph node harvest.
引用
收藏
页码:1152 / 1156
页数:5
相关论文
共 25 条
[1]  
Caplin S, 1998, CANCER, V83, P666, DOI 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.0.CO
[2]  
2-I
[3]   Adjuvant therapy in colon cancer - what, when and how? [J].
Chau, I. ;
Cunningham, D. .
ANNALS OF ONCOLOGY, 2006, 17 (09) :1347-1359
[4]   Lymph node recovery from colorectal tumor specimens: Recommendation for a minimum number of lymph nodes to be examined [J].
Cianchi, F ;
Palomba, A ;
Boddi, V ;
Messerini, L ;
Pucciani, F ;
Perigli, G ;
Bechi, P ;
Cortesini, C .
WORLD JOURNAL OF SURGERY, 2002, 26 (03) :384-389
[5]   Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? [J].
Cserni, G ;
Vinh-Hung, V ;
Burzykowski, T .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (02) :63-69
[6]   Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years - Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities [J].
Goldstein, NS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (02) :179-189
[7]   The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: A meta-analysis [J].
Iddings, Douglas ;
Ahmad, Aziz ;
Elashoff, David ;
Bilchik, Anton .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (11) :1386-1392
[8]   Increased lymph node harvest from colorectal cancer resections using GEWF solution: a randomised study [J].
Iversen, L. H. ;
Laurberg, S. ;
Hagemann-Madsen, R. ;
Dybdahl, H. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (11) :1203-1208
[9]   Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination [J].
Jestin, P ;
Påhlman, L ;
Glimelius, B ;
Gunnarsson, U .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) :2071-2078
[10]   Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer [J].
Johnson, Paul M. ;
Porter, Geoff A. ;
Ricciardi, Rocco ;
Baxter, Nancy N. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) :3570-3575